Inhibiting the Jumonji Family: A Potential New Clinical Approach to Targeting Aberrant Epigenetic Mechanisms

References

• Jones PA , BaylinSB . The fundamental role of epigenetic events in cancer . Nat. Rev. Genet.3 ( 6 ), 415 – 428 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Geutjes EJ , BajpePK , BernardsR . Targeting the epigenome for treatment of cancer . Oncogene31 ( 34 ), 3827 – 3844 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Vendetti FP , RudinCM . Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases . Expert Opin. Biol. Ther.13 ( 9 ), 1273 – 1285 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Dawson MA , KouzaridesT . Cancer epigenetics: from mechanism to therapy . Cell150 ( 1 ), 12 – 27 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Klose RJ , KallinEM , ZhangY . JmjC-domain-containing proteins and histone demethylation . Nat. Rev. Genet.7 ( 9 ), 715 – 727 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Hoffmann I , RoatschM , SchmittMLet al. The role of histone demethylases in cancer therapy . Mol. Oncol.6 ( 6 ), 683 – 703 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Hojfeldt JW , AggerK , HelinK . Histone lysine demethylases as targets for anticancer therapy . Nat. Rev. Drug Discov.12 ( 12 ), 917 – 930 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Pilka ES , JamesT , LisztwanJH . Structural definitions of Jumonji family demethylase selectivity . Drug Discov. Today20 ( 6 ), 743 – 749 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Takeuchi T , YamazakiY , Katoh-FukuiYet al. Gene trap capture of a novel mouse gene, Jumonji, required for neural tube formation . Genes Dev.9 ( 10 ), 1211 – 1222 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Johansson C , TumberA , CheKet al. The roles of Jumonji-type oxygenases in human disease . Epigenomics6 ( 1 ), 89 – 120 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Takeuchi T , WatanabeY , Takano-ShimizuT , KondoS . Roles of Jumonji and Jumonji family genes in chromatin regulation and development . Dev. Dyn.235 ( 9 ), 2449 – 2459 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Lan F , NottkeAC , ShiY . Mechanisms involved in the regulation of histone lysine demethylases . Curr. Opin. Cell Biol.20 ( 3 ), 316 – 325 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Yang J , LedakiI , TurleyHet al. Role of hypoxia-inducible factors in epigenetic regulation via histone demethylases . Ann. NY Acad. Sci.1177185 – 197 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Yang J , JubbAM , PikeLet al. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth . Cancer Res.70 ( 16 ), 6456 – 6466 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Zhang L , SokolowskiN , AtmadibrataB , LiuT . Histone demethylase JARID1B promotes cell proliferation but is downregulated by N-Myc oncoprotein . Oncol. Rep.31 ( 4 ), 1935 – 1939 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Huang Y , LiuY , YuLet al. Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer . Tumour Biol.36 ( 1 ), 271 – 278 ( 2015 ).
   PubMedGoogle Scholar
• Zhao L , LiW , ZangWet al. JMJD2B promotes epithelial-mesenchymal transition by cooperating with beta-catenin and enhances gastric cancer metastasis . Clin. Cancer Res.19 ( 23 ), 6419 – 6429 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hogarty MD . Expanding MYCN’s reach in oncogenic transcription . J. Natl Cancer Inst.107 ( 6 ), djv122 ( 2015 ).
   PubMedGoogle Scholar
• Agger K , CloosPA , RudkjaerLet al. The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence . Genes Dev.23 ( 10 ), 1171 – 1176 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Watanabe S , WatanabeK , AkimovVet al. JMJD1C demethylates MDC1 to regulate the RNF8 and BRCA1-mediated chromatin response to DNA breaks . Nat. Struct. Mol. Biol.20 ( 12 ), 1425 – 1433 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sun BB , FuLN , WangYQet al. Silencing of JMJD2B induces cell apoptosis via mitochondria-mediated and death receptor-mediated pathway activation in colorectal cancer . J. Dig. Dis.15 ( 9 ), 491 – 500 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wang L , ChangJ , VargheseDet al. A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth . Nat. Commun.4 , 2035 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wu J , LiuS , LiuGet al. Identification and functional analysis of 9p24 amplified genes in human breast cancer . Oncogene31 ( 3 ), 333 – 341 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Black JC , ManningAL , Van RechemCet al. KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors . Cell154 ( 3 ), 541 – 555 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wang L , MaoY , DuG , HeC , HanS . Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer . Tumour Biol.36 ( 4 ), 2465 – 2472 ( 2015 ).
   PubMedGoogle Scholar
• Rose NR , McDonoughMA , KingON , KawamuraA , SchofieldCJ . Inhibition of 2-oxoglutarate dependent oxygenases . Chem. Soc. Rev.40 ( 8 ), 4364 – 4397 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Gale M , YanQ . High-throughput screening to identify inhibitors of lysine demethylases . Epigenomics7 ( 1 ), 57 – 65 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kemper K , De GoejePL , PeeperDS , Van AmerongenR . Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy . Cancer Res.74 ( 21 ), 5937 – 5941 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Knoechel B , RoderickJE , WilliamsonKEet al. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia . Nat. Genet.46 ( 4 ), 364 – 370 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Maes T , CarcellerE , SalasJ , OrtegaA , BuesaC . Advances in the development of histone lysine demethylase inhibitors . Curr. Opin. Pharmacol.23 , 52 – 60 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Roesch A , VulturA , BogeskiIet al. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells . Cancer Cell23 ( 6 ), 811 – 825 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Rotili D , TomassiS , ConteMet al. Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities . J. Med. Chem.57 ( 1 ), 42 – 55 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Sharma SV , LeeDY , LiBet al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations . Cell141 ( 1 ), 69 – 80 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Bayo J , DalviMP , MartinezED . Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential . Future Med. Chem.7 ( 16 ), 2243 – 2261 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kruidenier L , ChungCW , ChengZet al. A selective Jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response . Nature488 ( 7411 ), 404 – 408 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Heinemann B , NielsenJM , HudlebuschHRet al. Inhibition of demethylases by GSK-J1/J4 . Nature514 ( 7520 ), E1 – E2 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Hashizume R , AndorN , IharaYet al. Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma . Nat. Med.20 ( 12 ), 1394 – 1396 ( 2014 ).
   PubMed Web of Science ®Google Scholar